The evaluation of selected oxidative stress parameters in patients with hyperthyroidism;Ocena wybranych parametrów stresu oksydacyjnego u chorych z nadczynnościa̧ tarczycy

Polskie Archiwum Medycyny Wewnetrznej

Volumn 117, Issue 7, 2007, Pages 285-289

  Andryskowski, Grzegorz ^a   Owczarek, Tomasz ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Hyperthyroidism; Oxidant antioxidant balance; Oxidative stress

Indexed keywords

ANTIOXIDANT; CATALASE; FREE RADICAL; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; OXIDIZING AGENT; OXYGEN; PROTEIN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; THIOL DERIVATIVE;

ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; BLOOD CHEMISTRY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE; EVALUATION; FEMALE; HUMAN; HYPERTHYROIDISM; MALE; OXIDATIVE STRESS; OXYGEN CONSUMPTION; QUANTITATIVE ANALYSIS;

EID: 35348929927     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.158     Document Type: Article

References (28)

1. Bartosz G. Druga twarz tlenu. PWN. Warszawa 2003.
2. Slater TF, Cheeseman KH, Davies MJ, et al. Free radical mechanisms in relation to tissue injury. Proceedings of the Nutrition Society. 1987; 46: 1-12.
3. Sies H. Oxidative Stress. New York, Academic Press, 1985.
4. Wiktorska JA, Sewerynek E, Lewinski A. Wpływ stanu tyreometabolicznego na proces peroksydacji lipidów (I): hipertyreoza. Clin Exp Med Lett. 2006; 47: 9-15.
5. Videla LA. Energy metabolism, thyroid calorigenesis, and oxidative stress: functional and cytotoxic consequences. Redox Report. 2000; 5: 265-275.
6. Misra HP, Fridovich J. The role of superoxide anion in the autoxidation of epinephrine and a simple assay superoxide dismutase. J Biol Chem. 1972; 247: 3170-3175.
7. Beers RF Jr, Sizer IW. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem. 1952; 195: 133-140.
8. Little C, O'Brien P. An intracellular GSH peroxidase with a lipid peroxide substrate. Biochem Biophys Res Commun. 1968; 31: 145-150.
9. Placer ZA, Cushman LL, Johnson BC. Estimation of product of lipid peroxidation (malonyl dialdehyde) in biochemical systems. Anal Biochem. 1966; 16: 359-364.
10. Rice-Evans CA, Diplock AT, Symons MCR. Techniques in free radicals research. In: Burdon RH, van Knippenberg PH, eds. Laboratory techniques in biochemistry and molecular biology. Amsterdam, London, New York, Tokyo, Elsevier, 1991.
11. Benzie IF, Strain JJ. Ferric reducing/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Methods Enzymol. 1999; 299: 15-27.
12. Paget GE, Torp JM. An effect of thyroxin on the fine structure of the rat liver cell. Nature. 1963; 199: 1307-1308.
13. Wajdowicz A, Da̧broś W, Zaczek M. Myocardial damage in thyrotoxicosis - ultrastructural studies. Pol J Pathol. 1996; 47: 127-133.
14. Nishizawa Y, Fushiki S, Amakata Y, et al. Thyroxine-induced production of superoxide anion by human alveolar neutrophils and macrophages: a possible mechanism for the exacerbation of bronchial asthma with the development of hyperthyroidism. In Vivo. 1998; 12: 253-257.
15. Bednarek J, Wysocki H, Sowinski J. The effect of one-month antithyroid therapy on peripheral metabolism of reactive oxygen species in Graves' disease with infiltrative ophthalmopathy. Przegl Lek. 2004; 61: 841-844.
16. Huh K, Kwon TH, Kim JS, et al. Role of the hepatic xanthine oxidase in thyroid dysfunction: effect of thyroid hormones in oxidative stress in rat liver. Arch Pharm Res. 1998; 21: 236-240.
17. Fernandez V, Barrientos X, Kipreos K, et al. Superoxide radical generation, NADPH oxidase activity, and cytochrome P-450 content of rat liver microsomal fractions in an experimental hyperthyroid state: relation to lipid peroxidation. Endocrinology. 1985; 117: 496-501.
18. Mayer L, Romic Z, Skreb F, et al. Antioxidants in patients with hyperthyroidism. Clin Chem Lab Med. 2004; 42: 154-158.
19. Wilson R, Chopra M, Bradley H, et al. Free radicals and Graves' disease: the effects of therapy. Clin Endocrinol (Oxf). 1989; 30: 429-33.
20. Komosinska-Vassev K, Olczyk K, Kucharz EJ, et al. Free radical activity and antioxidant defense mechanisms in patients with hyperthyroidism due to Graves' disease during therapy. Clin Chim Acta. 2000; 300: 107-117.
21. Seven A, Tasan E, Hatemi H, et al. The impact of propylthiouracil therapy on lipid peroxidation and antioxidant status parameters in hyperthyroid patients. Acta Med Okayama. 1999; 53: 27-30.
22. Ademoglu E, Gokkusu C, Yarman S, et al. The effect of methimazole on the oxidant and antioxidant system in patients with hyperthyroidism. Pharmacol Res. 1998; 38: 93-96.
23. Bednarek J, Wysocki H, Sowinski J. Oxidative stress peripheral parameters in Graves' disease: the effect of methimazole treatment in patients with and without infiltrative ophthalmopathy. Clin Biochem. 2005; 38: 13-18.
24. Guerra LN, Moiguer S, Kamer M, et al. Antioxidants in the treatment of Graves' disease. IUBMB Life. 2001; 51: 105-109.
25. Costantini F, Pierdomenico SD, De Cesare D, et al. Effect of thyroid function on LDL oxidation. Arterioscler Thromb Vasc Biol. 1998; 18: 732-737.
26. Bianchi G, Solarali E, Zaccheroni V, et al. Oxidative stress and anti-oxidant metabolites in patients with hyperthyroidism: effect of treatment. Horm Metab Res. 1999; 31: 620-624.
27. Mano T, Sinohara R, Sawai Y, et al. Changes in lipid peroxidation and free radical scavengers in the brain of hyper- and hypothyroid aged rats. J Endocrinol. 1995; 147: 361-365.
28. Ademoglu E, Ozbey N, Erbil Y, et al. Determination of oxidative stress in thyroid tissue and plasma of patients with Graves' disease. Eur J Intern Med. 2006; 17: 545-550.